| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.2M | +426.1% | — |
| R&D Expense | $29.0M | +17.0% | +17.1% |
| SG&A Expense | $21.0M | +1.6% | +71.1% |
| Operating Income | -$40.7M | +7.0% | -10.0% |
| Interest Expense | $319K | +50.5% | -72.2% |
| Income Tax | $0 | — | — |
| Net Income | -$98.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $137.7M | -16.2% | +21.7% |
| Inventory | $1.8M | +53.6% | — |
| Current Assets | $154.1M | -11.6% | +27.7% |
| Total Assets | $176.9M | -9.9% | +39.9% |
| Current Liabilities | $59.7M | +18.6% | +59.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$107.6M | — | — |
| Capital Expenditures | $28K | — | — |
| Investing Cash Flow | -$8.3M | — | — |
| Financing Cash Flow | $164.7M | — | — |
| Free Cash Flow | -$107.6M | — | — |
| -311.1% |
| EPS (Basic) | -$1.35 | -246.2% | -125.0% |
| EPS (Diluted) | -$1.35 | -117.7% | -125.0% |
| $40.7M |
| — |
| +0.5% |
| Total Liabilities | $192.4M | +20.1% | +104.3% |
| Stockholders' Equity | -$15.5M | -143.1% | -240.4% |